Clinical Trial Update: A Phase II Study of HS-10353 in Participants With Postpartum Depression [Phase 2]

View source ↗

Summary

Phase II trial update for HS-10353 in postpartum depression; status details are not provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Depression

Drugs mentioned

• HS-10353

Snippet

Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. | Conditions: Postpartum Depression | Phase 2 | Status: UNKNOWN